| Devatis AG - Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg), Tabletten | | 68472 | | 01 | | Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) | | Tabletten | | N04BA02 | | Levodopa und Decarboxylasehemmer | | 01.12.2021 | | |
| | Zusammensetzung | | benserazidum 12.5 mg ut benserazidi hydrochloridum, levodopum 50 mg, natrii docusas, E 172 (rubrum), ethylcellulosum, silica colloidalis anhydrica, cellulosum microcristallinum, amylum pregelificatum, mannitolum, calcii hydrogenophosphas, crospovidonum, magnesii stearas, pro compresso corresp. natrium 0.00259 mg. | | Packungsbestandteile | | Tabletten | | | | | Wirkstoffe | Stärke |
|---|
| Benserazidum | 12.5 mg | | Levodopa | 50 mg |
| | BAG: Wirkstoffe | Stärke |
|---|
| Benserazidum | 12.5 mg | | Levodopa | 50 mg |
| | | | Hilfsstoffe | | Zusätzliche Information |
|---|
| | | | | | | | | Calcii Hydrogenophosphas | | | | | | | | | | | | | | color. | | | | | | | | | | Mannitolum | | | | Natrii Docusas | | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 001 | 30 | 1.78 | 6.65 | B | | Nein | | 002 | 100 | 5.55 | 15.25 | B | SL | Nein |
|
|
